Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Probing the binding and antiparasitic efficacy of azobenzene G-quadruplex ligands to investigate G4 ligand design

  • Ramos-Soriano, Javier
  • Holbrow-Wilshaw, Maisie
  • Hunt, Eliza
  • Jiang, Y. Jennifer
  • Peñalver, Pablo
  • Morales, Juan Carlos
  • Galán, M. Carmen
This article is part of the themed collection: ChemComm 60th Anniversary Collection., Novel strategies against parasitic infections are of great importance. Here, we describe a G4 DNA ligand with subnanomolar antiparasitic activity against T. brucei and a remarkable selectivity index (IC50 MRC-5/T. brucei) of 2285-fold. We also correlate the impact of small structural changes to G4 binding activity and antiparasitic activity., MCG thanks ERC-COG: 648239, J. R.-S. thanks MSCA fellowship (project 843720-BioNanoProbes). E. H. thanks EPSRC EP/L015366/1 and J. Y. J. (EPSRC EP/L015366/1 and EP/S026215/1) for their PhD studentships. JCM thanks the Spanish Ministerio de Ciencia, Innovación y Universidades (Grant PID2021-127109OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DNA G-quadruplexes in the genome of Trypanosoma cruzi as potential therapeutic targets for Chagas disease: Dithienylethene ligands as effective antiparasitic agents

  • Pérez Soto, Manuel
  • Ramos-Soriano, Javier
  • Peñalver, Pablo
  • Belmonte-Reche, Efres
  • O'Hagan, Michael P.
  • Cucchiarini, Anne
  • Mergny, Jean-Louis
  • Galán, M. Carmen
  • López López, Manuel Carlos
  • Thomas, María del Carmen
  • Morales, Juan Carlos
Chagas disease is caused by the parasite Trypanosoma cruzi and affects over 7 million people worldwide. The two actual treatments, Benznidazole (Bzn) and Nifurtimox, cause serious side effects due to their high toxicity leading to treatment abandonment by the patients. In this work, we propose DNA G-quadruplexes (G4) as potential therapeutic targets for this infectious disease. We have found 174 PQS per 100,000 nucleotides in the genome of T. cruzi and confirmed G4 formation of three frequent motifs. We synthesized a family of 14 quadruplex ligands based in the dithienylethene (DTE) scaffold and demonstrated their binding to these identified G4 sequences. Several DTE derivatives exhibited micromolar activity against epimastigotes of four different strains of T. cruzi, in the same concentration range as Bzn. Compounds L3 and L4 presented remarkable activity against trypomastigotes, the active form in blood, of T. cruzi SOL strain (IC50 = 1.5-3.3 μM, SI = 25-40.9), being around 40 times more active than Bzn and displaying much better selectivity indexes., JCM thanks the funding by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-127109OB-I00). EBR received funding support from a Maria Zambrano fellowship, financed by NextGenerationEU/European Union. MCG thanks ERC-COG: 648239, EPSRC Funds EP/R043361/1, TS/R014329/1 and GCRF EP/T020288/1 for financial support and JRS thanks MSCA fellowship (project 843720-BioNanoProbes). A.C. and J.L.M. thank the generous benefactors of the Fondation X for their support. MCL and MCT were supported by grant PID2019-109090RB-I00/AEI/10.13039/501100011033 from the Programa Estatal I + D + I, Spanish Ministry of Science, Innovation and Universities (MICINN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bridged Azobenzene Exhibits Fully Reversible Photocontrolled Binding to a G‑Quadruplex DNA/Duplex Junction

  • Ramos-Soriano, Javier
  • Jiang, Y Jennifer
  • Deng, Bowen
  • O Hagan, Michael P
  • Rao, Aditya G
  • Lu, Doudou
  • Haldar, Susanta
  • Oliveira, A Sofia F
  • Mulholland, Adrian J
  • Galán, M. Carmen
The ability to selectively control DNA conformation using light as an external stimulus offers unique opportunities to control specific DNA sequences in biological settings and to develop nucleotide-based nanodevices. We describe a duplex/G-quadruplex (G4) junction-binding chemotype derived from a cyclic azobenzene core that reversibly photoswitches between cis and trans isomers, mediated exclusively by visible light under physiological conditions. We demonstrate the selective binding of the elongated trans conformation, with over 50-fold higher affinity, toward LTR-III G4 (an important HIV-1 sequence), and show that binding and dissociation from the LTR-III G4 can be controlled reversibly by alternate irradiation with low-intensity blue and green light. NMR and MD simulations indicate that the different isomers exhibit very distinct binding modes. While the elongated trans ligand preferentially binds at the G4/duplex junction of the LTR-III sequence, a DNA motif which is gaining increasing attention as a potential drug target, the bent cis isomer favors the duplex region., M.C.G. thanks ERC-COG: 648239, EPSRC Funds EP/R043361/1, TS/R014329/1, and GCRF EP/T020288/1 for financial support. JR-S thanks the MSCA fellowship (project 843720-BioNanoProbes) and Ramo\u0301n y Cajal fellow (RYC2022-037742-I) funded by MCIN/AEI/10.1339/501100011033 and by \u201CESF Investing in your future\u201D. ASFO was supported at the University of Bristol by the Biological and Biotechnological Sciences Research Council (grant [BB/X009831/1]). MD simulations were carried out using the University of Bristol High-Performing Computers, namely, Bluecrystal and Bluepebble. BD was supported by the UoB Strategic Fund Scholarship. M.P.O. and Y.J.J. thank the EPSRC (EP/L015366/1) for their PhD scholarships., Peer reviewed